NO920031L - SYNERGISTIC AGENT FOR THERAPEUTIC TREATMENT, PREPARATIONS CONTAINING THE ABOVE AGENT, AND USE OF THE AGENT FOR THE PREPARATION OF A MEDICINAL PREPARATION - Google Patents
SYNERGISTIC AGENT FOR THERAPEUTIC TREATMENT, PREPARATIONS CONTAINING THE ABOVE AGENT, AND USE OF THE AGENT FOR THE PREPARATION OF A MEDICINAL PREPARATIONInfo
- Publication number
- NO920031L NO920031L NO92920031A NO920031A NO920031L NO 920031 L NO920031 L NO 920031L NO 92920031 A NO92920031 A NO 92920031A NO 920031 A NO920031 A NO 920031A NO 920031 L NO920031 L NO 920031L
- Authority
- NO
- Norway
- Prior art keywords
- agent
- preparation
- synergistic
- therapeutic treatment
- methyl
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Oppfinnelsen angår synergistiske midler for behandling av inflammatoriske eller artrittiske tilstander som omfatter én av en utvalgt gruppe nemmere av enzymet 5-lipoksygenase sammen med, eller i blanding med, en hemmer av enzymet cyklooksygenase. 5-lpoksygenase-hemmeren er for eksempel 6-[(3-fluor-5-[4-metoksy-3,4,5,6-tetrahydro-2H-pyran-4-yl]-fenoksy)metyl]-l-metyl-2-kinolon eller 4-[5-fluor-3-(4-metyl-3-okso-2,3-dihydro-4H-l,4-benzoksazin-7-yltio)fenyl]-4-metoksytetrahydropyran og cykloksygenase-hemmeren er valgt fra indometacin, flurbiprofen og diklofenak.Oppfinnelsen angår også et farmasøytisk preparat som inneholder nevnte synergistiske middel, og bruken av nevnte middel ved fremstilling av et medikament for synergistisk behandling av inflammatoriske eller artrittiske lidelser.The invention relates to synergistic agents for the treatment of inflammatory or arthritic conditions which comprise one of a selected group of the enzyme 5-lipoxygenase together with, or in admixture with, an inhibitor of the enzyme cyclooxygenase. The 5-epoxygenase inhibitor is, for example, 6 - [(3-fluoro-5- [4-methoxy-3,4,5,6-tetrahydro-2H-pyran-4-yl] -phenoxy) methyl] -1-methyl -2-quinolone or 4- [5-fluoro-3- (4-methyl-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-7-ylthio) phenyl] -4-methoxytetrahydropyran and cycloxygenase The invention also relates to a pharmaceutical composition containing said synergistic agent, and the use of said agent in the manufacture of a medicament for the synergistic treatment of inflammatory or arthritic disorders.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO92920031A NO920031L (en) | 1992-01-02 | 1992-01-02 | SYNERGISTIC AGENT FOR THERAPEUTIC TREATMENT, PREPARATIONS CONTAINING THE ABOVE AGENT, AND USE OF THE AGENT FOR THE PREPARATION OF A MEDICINAL PREPARATION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO92920031A NO920031L (en) | 1992-01-02 | 1992-01-02 | SYNERGISTIC AGENT FOR THERAPEUTIC TREATMENT, PREPARATIONS CONTAINING THE ABOVE AGENT, AND USE OF THE AGENT FOR THE PREPARATION OF A MEDICINAL PREPARATION |
Publications (2)
Publication Number | Publication Date |
---|---|
NO920031D0 NO920031D0 (en) | 1992-01-02 |
NO920031L true NO920031L (en) | 1993-07-05 |
Family
ID=19894742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92920031A NO920031L (en) | 1992-01-02 | 1992-01-02 | SYNERGISTIC AGENT FOR THERAPEUTIC TREATMENT, PREPARATIONS CONTAINING THE ABOVE AGENT, AND USE OF THE AGENT FOR THE PREPARATION OF A MEDICINAL PREPARATION |
Country Status (1)
Country | Link |
---|---|
NO (1) | NO920031L (en) |
-
1992
- 1992-01-02 NO NO92920031A patent/NO920031L/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO920031D0 (en) | 1992-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ505453A (en) | Hypolipidemic benzothiazepine compounds | |
ES2069410T3 (en) | NEW DERIVATIVES OF HYDROXAMIC ACID AND N-HYDROXYUREA AND ITS USE. | |
KR870700599A (en) | Carboxylic acid derivatives, methods for their preparation, pharmaceutical compositions containing these compounds and uses thereof | |
BR9713921A (en) | Compound, pharmaceutical composition, process for logician capable of being modulated through factor xa inhibition | |
NO912888D0 (en) | PROCEDURE FOR THE PREPARATION OF NEW PEPERIDYLETHERS AND THIOETHERS. | |
DE3767114D1 (en) | STABILIZED MEDICINAL PRODUCTS. | |
NO912414D0 (en) | RELATIONSHIP WITH MAGIC ACID INHIBITING EFFECT AND PROCEDURE FOR ITS MANUFACTURING. | |
NO975726D0 (en) | N-Hydroxyurea derivatives as anti-inflammatory agents | |
NO920031L (en) | SYNERGISTIC AGENT FOR THERAPEUTIC TREATMENT, PREPARATIONS CONTAINING THE ABOVE AGENT, AND USE OF THE AGENT FOR THE PREPARATION OF A MEDICINAL PREPARATION | |
NO305595B1 (en) | Phenoxyphenylcyclopentyl hydroxyureas, pharmaceutical preparations and use thereof | |
AR002264A1 (en) | 6- [TRIAZOLIL [3 (TRIFLUORMETIL) FENIL] METHYL] -2-QUINOLINONES AND QUINOLINTIONS, A PROCEDURE FOR THEIR PREPARATION, A COMPOSITION THAT INCLUDES THEM, A PROCEDURE FOR THEIR PREPARATION, THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT INTERMEDIARY. | |
FI932654A0 (en) | Hydroxamsyraderivat, som hindrar lipoxigenas | |
BR9916733A (en) | Arylalkanine derivatives, processes for their preparation, their use and pharmaceutical compositions containing them | |
DK449488D0 (en) | DISUBSTITUTED TETRAZOLAL COMPOUNDS WITH LEUKOTRIEN ANTAGONIST EFFECTS, METHODS FOR PREPARING THEM AND METHOD OF USING THE PROCEDURE | |
BR9815690A (en) | Compound, process for the preparation of any of the compounds, pharmaceutical composition, and, use of the compound of 3- (nafter-1-yl-oxy) - pyrrolidine, 3- (5,6,7,8 - tetrahydro-nafterc- 1-yl-oxy) - pyrrolindine | |
NO996311L (en) | Removable paclitaxel shaft sealants |